I am always looking for opportunities to cover new companies. Sometimes I find new companies that initially look interesting for investment, but after a closer look at the financials, it turns out ...
Fresenius Medical Care (FMS) and Fresenius (FRE) stocks have experienced a decline due to the Novo Nordisk drug Ozempic ending a kidney failure study early. FMS remains a good player in the dialysis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results